Holen Sie sich die Stockscreener-App
8.3953
2.44%
0.1953
Schlusskurs vom Vortag:
$8.20
Offen:
$8.28
24-Stunden-Volumen:
11.82M
Relative Volume:
1.09
Marktkapitalisierung:
$5.68B
Einnahmen:
$6.55B
Nettoeinkommen (Verlust:
$-530.20M
KGV:
-10.80
EPS:
-0.7777
Netto-Cashflow:
$495.00M
1W Leistung:
+5.00%
1M Leistung:
+5.93%
6M Leistung:
-39.44%
1J Leistung:
-45.45%
1-Tages-Spanne:
$8.26
$8.485
1-Wochen-Bereich:
$7.645
$8.485
52-Wochen-Spanne:
$7.265
$16.17
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
8.395 | 5.54B | 6.55B | -530.20M | 495.00M | -0.7777 |
ISRG
Intuitive Surgical Inc
|
468.76 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.05 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.84 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.84 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.82 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Herabstufung | Jefferies | Hold → Underperform |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Avantor stock up as new lab capabilities improve biopharma support - MSN
Avantor India Expands its Strategic Collaboration with Parafilm to Serve the Indian Laboratory Consumables Market - ANTARA News
Research Tools & Consumables Stocks Q4 In Review: Avantor (NYSE:AVTR) Vs Peers - TradingView — Track All Markets
Avantor slides on revised outlook, revenue miss - MSN
Barclays Maintains Avantor(AVTR.US) With Sell Rating, Cuts Target Price to $7 - Moomoo
A Look At Avantor’s Valuation As It Expands Its North American Quality Control Hub - Yahoo Finance
Avantor Stock Up as New Lab Capabilities Improve Biopharma Support - Zacks Investment Research
Radnor-based Avantor opens St. Louis facility - Pennsylvania Business Report -
Avantor Inc stock (US05352A1007): Why supply chain resilience matters more now for investors - AD HOC NEWS
Avantor Adds Microbial, Stability Testing Capabilities to St. Louis Manufacturing Site - marketscreener.com
Analysts hold neutral stance on Avantor, Inc. (AVTR) amid lower valuation expectations - MSN
Avantor expands strategic collaboration with Parafilm to serve Indian lab consumables market - BioSpectrum India
Avantor expands quality control testing at St. Louis facility By Investing.com - Investing.com Canada
Avantor Inc stock (US05352A1007): Why supply chain resilience matters more now - AD HOC NEWS
Avantor expands St. Louis lab to speed testing for U.S. drugmakers - Stock Titan
Analysts Hold Neutral Stance on Avantor, Inc. (AVTR) Amid Lower Valuation Expectations - Insider Monkey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out - ACCESS Newswire
AVTR Technical Analysis & Stock Price Forecast - Intellectia AI
Should I invest in Avantor Inc before earningsWeekly Risk Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Avantor Inc stock (US05352A1007): Is its lab supply dominance strong enough for U.S. investor upside - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Avantor CFO Brent Jones to depart by June 2026 - MSN
Alpha Buying: Following Conviction, Not the CrowdAvantor (NYSE:AVTR), Baxter International (NYSE:BAX) - Benzinga
How Avantor’s (AVTR) CFO Transition Could Shape Its Financial Discipline and Strategic Execution - simplywall.st
Avantor CFO Brent Jones to Depart by June 2026 - MyChesCo
AVTR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Avantor, Inc. (AVTR) Stock Price, News, Quote & History - Yahoo! Finance Canada
[Form 4] Avantor, Inc. Insider Trading Activity - Stock Titan
Evercore Maintains Avantor(AVTR.US) With Hold Rating, Cuts Target Price to $8.5 - Moomoo
Sectors Review: Is Avantor Inc still a buy after recent gains2026 Growth vs Value & Accurate Buy Signal Notifications - baoquankhu1.vn
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - Sahm
Avantor, Inc. (AVTR) Q1 Earnings Meet Estimates - MSN
Why The Narrative Around Avantor (AVTR) Is Shifting After Target Cuts And Leadership Changes - Yahoo Finance
Avantor to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026 - bitget.com
Avantor, Inc. (AVTR) stock price, news, quote and history - Yahoo Finance Singapore
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Avantor (AVTR) and Veeva Systems (VEEV) - The Globe and Mail
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Shareholders to Learn More About the Investigation | NYSE:AVTR | Press Release - Stockhouse
ESAB Corporation Announces CFO Transition - Business Wire
Avantor CFO R Brent Jones to depart - MSN
SG Americas Securities LLC Acquires 272,093 Shares of Avantor, Inc. $AVTR - MarketBeat
Avantor® Announces CFO Transition - Sahm
Avantor CFO R. Brent Jones to depart by late June - Investing.com Canada
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance UK
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor stock holds at Market Perform as CFO departs, guidance intact - Investing.com India
How Investors Are Reacting To Avantor (AVTR) CFO Succession and Interim Finance Leadership Shift - simplywall.st
Avantor, Inc. Announces CFO Transition in April 2026 Press Release - Minichart
R. Brent Jones to Leave as Executive Vice President of Avantor, Inc., Effective on or Before June 24, 2026 - marketscreener.com
Avantor Announces CFO Resignation and Interim Finance Leadership - TipRanks
R. Brent Jones to Step Down as CFO of Avantor - citybiz
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):